MedicalMJ.org - News and Facts About Medical Marijuana

Chronicle AM: Fed Sentencing Reform Bill Looms, HHS Recommends Kratom Ban, More... (11/13/18)

Congress could move on both sentencing reform and industrial hemp in the lame duck session, HHS recommends banning kratom, Thailand moves to legalize and regulate both kratom and medical marijuana, and more.

[image:1 align:left caption:true]Sentencing Reform

Federal Sentencing Reform Bill Set to Advance. Key senators have reached a tentative agreement on a major criminal justice reform bill that is being supported by presidential advisor and Trump son-in-law Jared Kushner. The proposed legislation would boost rehabilitation efforts for federal prisoners and give judges more discretion when sentencing nonviolent offenders, particularly for drug offenses. The measure has support from both liberal and conservative groups, ranging from the ACLU to the Fraternal Order of Police and groups supported by the Koch brothers.

Marijuana Policy

Michigan Prosecutors Start Dropping Marijuana Cases. Local prosecutors are beginning to announce the dropping of charges in pending marijuana cases after voters last week voted to legalize the drug. Genesee County Prosecutor David Leyton said last Friday that "there will no longer be any prosecutions for possession or use of marijuana" in his jurisdiction, and other DAs are expected to follow suit.

Texas Lawmaker Files Marijuana Decriminalization Bill. State Rep. Joe Moody (D-El Paso) has prefiled a marijuana decriminalization bill for the 2019 legislative session. "Civil penalty legislation is the first thing I've filed on the first day of filing for the 86th Session. There's been an incredible swell of bipartisan support since last session, and the official Texas Republican and Democratic platforms both approve of this kind of reform now," Moody said in a press release. "I'm optimistic that this will be the session we finally see smarter, fairer marijuana laws in Texas."

Medical Marijuana

Connecticut Adds Chronic Neuropathic Pain to List of Qualifying Conditions. The General Assembly's Regulations Review Committee has agreed that chronic neuropathic pain associated with degenerative spinal disorders is eligible for treatment with the drug. That makes it the 31st specific condition considered a qualifier for medical marijuana.

Industrial Hemp

McConnell Says Hemp Provision Will Be in Farm Bill. Senate Majority Leader Mitch McConnell (R-KY) said Friday that completing work on a new farm bill is a top priority and that a provision to fully legalize hemp cultivation will be included.

Kratom

HHS Recommends Banning Kratom. The Department of Health and Human Services has recommended that kratom be placed in Schedule I of the Controlled Substances Act. HHS sent a letter to the DEA saying that two chemicals in the herbal supplement should be Schedule I. The recommendation is in line with past public statements from FDA Commissioner Scott Gottlieb, who calls kratom "an opioid" and says it has been "associated" with dozens of deaths.

International

Thai Congress Proposes Legalizing Kratom, Medical Marijuana. The National Legislative Assembly has officially proposed allowing the licensed use of medical marijuana and kratom. The two drugs would be placed in a legal category that would allow their licensed possession and distribution. The Health Ministry will review the proposal before submitting it to the cabinet, which could amend it before returning it to the legislature. The entire process could be completed by year's end.

Foreign Policy

Afghan Opium Problem "Worse Than Ever," Inspector General's Report Finds. Despite the US spending more than $8 billion to reduce opium cultivation in Afghanistan, the problem is "worse than ever," a new report from the Special Inspector General for Afghanistan Reconstruction (SIGAR) finds. "No counterdrug program undertaken… by the United States, its coalition partners, or the Afghan government resulted in lasting reductions in poppy cultivation or opium production," the report stated.



Chronicle AM: NYC Marijuana Busts Way, Way Down; New Federal Fentanyl Sentences in Effect, More... (11/9/18)

New York City marijuana possession arrests plummet (finally), Utah patients will have some legal protection beginning next month, federal fentanyl sentences just increased, and more.

[image:1 align:left caption:true]Marijuana Policy

Michigan US Attorneys Warn That Federal Prohibition Remains in Force. In a joint statement released Thursday, US Attorneys for Michigan Matthew Schneider and Andrew Birge warned that even though voters there legalized marijuana on Tuesday, "marijuana continues to be an illegal drug under federal law" and that they "will not unilaterally immunize anyone from prosecution for violating federal laws simply because of the passage of Proposal 1." That said, the federal prosecutors then conceded "our offices have never focused on the prosecution of marijuana users or low-level offenders" and that "as we weigh the interests in enforcing a law, we must also consider our ability to prosecute with our limited resources."

Arrests for Low-Level Marijuana Possession have Decreased 90 Percent Following New NYPD Marijuana Guidelines. Arrests for low-level marijuana possession have plummeted 90 percent since new NYPD marijuana enforcement guidelines took effect in September. There were 151 arrests for low-level marijuana in the entire city of New York in September 2018, less than 10 percent of the 1,500+ arrests last September and 3 percent of the 4,300+ arrests that took place in September 2010. However, racial disparities in enforcement still persist, with Blacks and Latino people comprising around 80 percent of the 1,000 summonses issued for marijuana.

Medical Marijuana

Utah Patients Will Have Legal Protections Beginning December 1. Although it could take months or years for the state to get a medical marijuana cultivation and distribution system up and running, medical marijuana patients will win some protections from arrest and prosecution beginning on December 1. That's because the Prop 2 initiative approved by voters includes an "affirmative defense" provision protecting them from a criminal conviction. It doesn't explicitly protect patients from arrest, but the hope is that with little likelihood of a successful prosecution, police will have little incentive to actually arrest patients.

Heroin and Prescription Opioids

Harsher Federal Penalties for Selling Fentanyl-Laced Drugs Are Now in Effect. New federal sentencing guidelines that went into effect November 1 significantly increase the possible prison sentence faced by people who sell heroin or cocaine laced with fentanyl. The new guidelines "create a four-level enhancement for a defendant who knowingly misrepresents or knowingly markets as another substance a mixture containing fentanyl or a fentanyl analog," which translates into sentences nearly twice as long as previously. While the guidelines only apply to someone who intentionally sought to deceive buyers, the realities of the federal criminal justice system -- where the vast majority of cases end with plea bargains -- mean that prosecutors will rarely have to prove the intent to deceive.



Green Wave Update: Marijuana Initiatives Go Three for Four in Midterms, and More [FEATURE]

The expansion of legal marijuana continued apace in Tuesday's elections, with medical marijuana initiatives winning in Missouri and Utah and recreational marijuana winning in Michigan. The only loss for weed came in North Dakota, where voters approved medical marijuana two years ago but weren't ready to take the next step this year.

[image:1 align:left caption:true]Michigan becomes the 10th state to legalize marijuana and the first one in the Midwest. With Missouri and Utah now joining the ranks, medical marijuana is now legal in 32 states.

In Michigan, the Proposal 1 legalization initiative was winning with 55.8 percent of the vote, with 96 percent of the vote counted as of Wednesday morning. The measure will legalize, regulate, and tax marijuana in Michigan for adults aged 21 and older. It allows for the possession of up to 2.5 ounces of marijuana and cultivation of up to 12 plants for personal use, while also establishing a legal framework for the licensing and regulation of marijuana businesses and products.

"The passage of Proposal 1 is a major milestone for marijuana policy reform in the US," said Matthew Schweich, deputy director of the Marijuana Policy Project (MPP) and campaign director for the Yes on 1 campaign. "Michigan will be the first state in the Midwest to end marijuana prohibition and replace it with a system in which marijuana is regulated for adult use. Adults will no longer be punished for consuming a substance less harmful than alcohol, and rather than having to resort to the illegal market, they will be able to access it safely and legally from licensed businesses. In addition to the public health and safety benefits associated with regulating marijuana, the state will have a significant new stream of tax revenue. Michigan is going to demonstrate that regulating marijuana works, and it will set a strong example for other states in the region and around the country."

"Western and northeastern states have led the way on legalizing marijuana, but the victory in Michigan powerfully demonstrates the national reach of this movement," said Maria McFarland Sánchez-Moreno, executive director of the Drug Policy Alliance (DPA), which through its lobbying arm, Drug Policy Action, helped fund and played a significant role in drafting the initiative. "With such overwhelming public support for marijuana legalization, even including majorities of Republicans and older Americans, there's only so long that the federal government can continue to hold out."

In the past decade, Michigan has seen more than 200,000 marijuana arrests, the vast majority (84 percent) for simple possession. Those arrests won't be happening anymore.

In Missouri, two of three medical marijuana initiatives won. Amendment 3, which would have imposed a 15 percent tax and set up a research institute benefiting its author, was easily defeated, while Amendment 2 had 65.5 percent support, and Proposition C had 56.5 percent. Amendment 2 was backed by both MPP and DPA.

"Thanks to the unflagging efforts of patients and advocates, Missourians who could benefit from medical marijuana will soon be able to use it without fear of being treated like criminals," said MPP's Schweich. "We hope lawmakers will implement the measure efficiently and effectively to ensure qualified patients can gain access to their medicine as soon as possible."

In North Dakota, the cold wind of prairie conservatism and the Red Wave that swamped Sen. Heidi Heitkamp (D) was strong enough to overwhelm the Measure 3 legalization initiative. It managed to garner only 40.5 percent of the vote. Measure 3 was a grassroots effort with little outside support and strong and deep-pocketed opposition.

In Utah, despite the machinations of the Mormon Church and the state's Republican political establishment, which sought to blunt support for Proposition 2 by promising to pass some sort of medical marijuana bill later this year, voters weren't willing to wait. Prop 2 had 53.2 percent of the votes, with 76 percent of precincts reporting. Even in Deep Red Utah, medical marijuana wins.

Drug reformers pronounced themselves pleased with the results and pressed for federal action to end marijuana prohibition.

"This is yet another historic election for the movement to end marijuana prohibition. Voters have once again sent a message loud and clear that it is time to legalize and regulate marijuana," said MPP executive director Steve Hawkins. "Marijuana has now been legalized for adult use in one out of every five states, so I think it's safe to say federal laws are in need of an update. We hope the results of this election will inspire Congress to finally start addressing the tension that exists between state and federal marijuana laws in our nation."

But wait, there's more. Voters in a number of Wisconsin localities, including the population centers of Madison and Milwaukee, overwhelmingly approved non-binding referenda calling for marijuana legalization, while voters approved decriminalization in five out of six Ohio cities where it was on the ballot, including Dayton.

Democratic gubernatorial candidates embracing marijuana legalization (and broader drug reform), including Gavin Newsom (CA), Jared Polis (CO), J.B. Pritzker (IL), and Michelle Lujan Grisham (NM), all emerged victorious. The last two are especially notable since, as chief executives of as yet pot prohibitionist states, they can guide their states to legalization.

And in one of the sweeter outcomes of the Democrats' retaking of the House, one of the biggest obstacles to marijuana reform in Congress, Rep. Pete Sessions (R-TX), lost to Democrat Colin Allred, a supporter of marijuana reform. As chairman of the House Rules Committee, Sessions repeatedly blocked reform measures from advancing. But his time has come and gone.

All in all, election day was a pretty good day for weed.

This article was produced by Drug Reporter, a project of the Independent Media Institute.

The Drug Policy Alliance is a financial supporter of both Drug Reporter and Drug War Chronicle.



Relative Addictive Properties of Various Commonly Used Drugs

relative dangers and addictive properties of various drugs
Source: Dr. Jack E. Henningfield, Ph.D. for NIDA. Reported by: Philip J. Hilts, New York Times, Aug. 2, 1994 "Is Nicotine Addictive? It Depends on Whose Criteria You Use."
Image courtesy of Drug War Facts.

Medical Marijuana News Update

Marijuana is medicine for millions of patients around the US. Click here for medical marijuana news. Federal opposition persists in spite of successful medical marijuana programs in several states. States, cities moving to allow medical use by those in need.

For more information on medical marijuana and other drug policy reform issues, check out the Common Sense for Drug Policy. For the facts about medical marijuana, check out Drug War Facts: Medical Marijuana, and this CSDP public service ad on medical cannabis to learn more.


For The Latest News Check Out:

Common Sense for Drug Policy

Americans For Safe Access

Media Awareness Project

Drug Reform Coordination Network


Support The Campaign!

Support the Coalition campaign! To make a tax-deductible donation click here.


Get Active!

Help make sure that patients can access medical cannabis safely and legally. Americans for Safe Access maintains this terrific Take Action page on their site to help you decide what actions you can take. Common Sense for Drug Policy also maintains this organizers' toolkit on their website.


Meet The Patients

The US Justice Department continues to stand between patients and their medicine. Click here to meet some of the patients and read their stories, and learn why this issue is so important.


The drug war lies on a foundation of myth. Learn the truth. Get the facts. Drug War Facts is your premier information source, offering uptodate information with full citations to aid in further research. Individual sections as well as full edition available electronically at DrugWarFacts.org. Get the facts about medical marijuana, prisons, drug treatment, syringe exchange, and more.
Help spread the word! Put a Drug War Facts banner on YOUR website. Click here for more info.


Marijuana Is Safe, Effective Medicine

Cannabis, or marijuana as it is often called when referring to the drug form of the plant, is an effective medicine that is relatively safer than many commonly-used pharmaceutical products. In the last several decades US doctors and patients have been denied legal access to this substance. Click here to read this well-researched article about the medical benefits of cannabis and learn more about its uses.


Get Informed!

Get the facts about medical cannabis from Drug War Facts.
NORML's website provides a great deal of useful medical cannabis information. California NORML maintains this list of CA medical cannabis resources. Access hundreds of articles on medical cannabis from the popular press.


The US Justice Department is pressing forward with an aggressive campaign to prosecute medical marijuana offenders in spite of California's medical marijuana law (Prop 215) and in defiance of efforts by local officials to support legal medicine for patients. Targets have included prominent medical marijuana patients groups, caregivers, and individual patients attempting to grow medicine for themselves.... Click here for more.


Top Stories On The Web

US MA: Massachusetts Marijuana Retailers May Soon Get Final Go-Ahead

Worcester Telegram & Gazette, 09 Sep 2018 - BOSTON - A handful of the marijuana businesses granted provisional licenses have informed the Cannabis Control Commission they are ready to be inspected, one of the final steps before retail sales of marijuana, approved by voters almost two years ago, can begin. CCC Chairman Steven Hoffman said late last week the agency is working to schedule inspections for two or three provisionally licensed businesses. Hoffman said the inspections are expected to take place "over the next week, plus or minus."

US MA: Northboro And Bellingham Now Told They Cannot Prohibit Medical

Worcester Telegram & Gazette, 10 Sep 2018 - Six days after confirming approval of medical marijuana dispensary bans in Northboro and Bellingham, Attorney General Maura Healey's office reversed its decision. In an Aug. 25 Telegram & Gazette story, a spokesperson for the AG's office confirmed that the office in June approved bylaws passed in the two towns that ban medical marijuana dispensaries. The 2012 Medical Marijuana law originally prohibited any municipality from banning medical marijuana dispensaries. An AG spokeswoman said at the time the approval was based on Section 56 (subsection d) of Chapter 55 Acts of 2017.

US FL: In Sarasota, Panelists Insist Cannabis Can Reduce Addictive

Sarasota Herald-Tribune, 07 Sep 2018 - SARASOTA -- Several panelists made their cases in a Thursday forum for why marijuana should no longer be classified by the federal government as a Schedule 1 drug as dangerous as heroin. The program focused on the Herald-Tribune project "Warriors Rise Up," which found a gaping rift between what many combat veterans want to treat their post-traumatic stress disorder and traumatic brain injuries and what they can legally get.

US IL: Medical Marijuana Sellers See New Law As A Win For

Chicago Tribune, 06 Sep 2018 - PATIENTS: 'WE ARE THRILLED' Medical pot sellers in the north suburbs are lauding a new Illinois law that will eventually allow patients who might be prescribed an opioid-based painkiller to qualify for medical marijuana as an alternative.

US PA: A 'Game-Changer' For Pa. Medical Marijuana Flower Goes On Sale

Philadelphia Daily News, 27 Jul 2018 - NEXT WEEK Medical marijuana dispensaries in Pennsylvania are bracing for a surge in new customers when vaporizable "flower" -- the most popular and recognizable form of cannabis -- goes on sale on Wednesday, Aug. 1.

US: 'Marijuana Is A Gift From God'

Los Angeles Times, 29 Jul 2018 - An LDS missionary passes by the Salt Lake Temple at Temple Square in Salt Lake City. Voters this fall in Utah will cast ballots on a measure that would allow medical marijuana. (Isaac Hale / For The Times) Brian Stoll faced a dilemma as his wedding day approached. For more than a year, he had been smoking marijuana to treat severe back pain, but to remain in good standing with the Church of Jesus Christ of Latter-day Saints and get married in the temple, he had to stop using pot.

US: Public Faith In Marijuana Outpaces Medical Research, Study Finds

Philadelphia Daily News, 25 Jul 2018 - Despite limited evidence, Americans have an increasingly positive view of the health benefits of marijuana. Nearly two-thirds believe pot can reduce pain, while close to half say it improves symptoms of anxiety, depression, epilepsy, and multiple sclerosis, according to a new online survey of 9,003 adults. Pennsylvania and New Jersey are among the 30 states, along with the District of Columbia, Guam, and Puerto Rico, that have legalized medical marijuana. But scientists say hard data on the health effects of pot -- both positive and negative -- are largely missing. Because marijuana is considered an illicit drug by the federal government, research has been scant, though there are efforts underway in Pennsylvania and nationally to remedy that.

US: Marijuana Bills Increasingly Focus On Social Justice

Philadelphia Daily News, 19 Jul 2018 - State lawmakers and advocates pushing to legalize marijuana this year aren't just touting legalization as a way to raise tax revenue and regulate an underground pot market. They're also talking about fixing a broken criminal justice system and reinvesting in poor and minority communities that have been battered by decades of the government's war on drugs. The focus on justice and equity has sharpened over time, longtime pot advocates say, as it's become clear that such issues should be addressed and that doing so won't alienate voters -- most of whom, polls consistently show, support legal marijuana. Civil rights groups also have raised their voices in legalization discussions.

US PA: Could Marijuana Help Treat Opioid Addiction? Pennsylvania May

Philadelphia Daily News, 06 Jul 2018 - As bad as getting off opioids the first time was, nothing prepared Briana Kline for trying to come back from relapse. She was in deep, past the Percocets and other pills. This time it was heroin, even a close brush with fentanyl. But the medicine that so helped slay her cravings before didn't seem to be cutting it. "The Suboxone didn't make me feel the way it usually does," said Kline, 26, of Lancaster County. "I was struggling a lot with cravings. I'd go a couple of days, be OK. Then I'd go use again."

Medical Marijuana

Courtesy of Drug War Facts, a project of Common Sense for Drug Policy.

  1. Since 1996, ten states have legalized medical marijuana use: AK, AZ, CA, CO, HI, ME, NV, OR, VT and WA. Eight of the ten did so through the initiative process, Hawaii's law was enacted by the legislature and signed by the governor in 2000, and Vermont's was enacted by the legislature and passed into law without the governor's signature in May 2004.

    Source:  National Organization for the Reform of Marijuana Laws (NORML), from the web at http://www.norml.org/index.cfm?Group_ID=3391, last accessed Oct. 9, 2004.

  2. The Institute of Medicine's 1999 report on medical marijuana stated, "The accumulated data indicate a potential therapeutic value for cannabinoid drugs, particularly for symptoms such as pain relief, control of nausea and vomiting, and appetite stimulation."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  3. The Institute of Medicine's 1999 report on medical marijuana examined the question whether the medical use of marijuana would lead to an increase of marijuana use in the general population and concluded that, "At this point there are no convincing data to support this concern. The existing data are consistent with the idea that this would not be a problem if the medical use of marijuana were as closely regulated as other medications with abuse potential." The report also noted that, "this question is beyond the issues normally considered for medical uses of drugs, and should not be a factor in evaluating the therapeutic potential of marijuana or cannabinoids."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  4. In the Institute of Medicine's report on medical marijuana, the researchers examined the physiological risks of using marijuana and cautioned, "Marijuana is not a completely benign substance. It is a powerful drug with a variety of effects. However, except for the harms associated with smoking, the adverse effects of marijuana use are within the range of effects tolerated for other medications."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  5. The Institute of Medicine's 1999 report on medical marijuana examined the question of whether marijuana could diminish patients' immune system - an important question when considering marijuana use by AIDS and cancer patients. The report concluded that, "the short-term immunosuppressive effects are not well established but, if they exist, are not likely great enough to preclude a legitimate medical use."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  6. "Conclusions: Smoked and oral cannabinoids did not seem to be unsafe in people with HIV infection with respect to HIV RNA levels, CD4+ and CD8+ cell counts, or protease inhibitor levels over a 21-day treatment."

    Source:  Abrams, Donald I., MD, et al., "Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection - A Randomized, Placebo-Controlled Clinical Trial," Annals of Internal Medicine, Aug. 19, 2003, Vol. 139, No. 4 (American College of Physicians), p. 258.

  7. "This study provides evidence that short-term use of cannabinoids, either oral or smoked, does not substantially elevate viral load in individuals with HIV infection who are receiving stable antiretroviral regimens containing nelfinavir or indinavir. Upper confidence bounds for all estimated effects of cannabinoids on HIV RNA level from all analyses were no greater than an increase of 0.23 log10 copies/mL compared with placebo. Because this study was randomized and analyses were controlled for all known potential confounders, it is very unlikely that chance imbalance on any known or unknown covariate masked a harmful effect of cannabinoids. Study participants in all groups may have been expected to benefit from the equivalent of directly observed antiretroviral therapy, as well as decreased stress and, for some, improved nutrition over the 25-day inpatient stay."

    Source: Abrams, Donald I., MD, et al., "Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection - A Randomized, Placebo-Controlled Clinical Trial," Annals of Internal Medicine, Aug. 19, 2003, Vol. 139, No. 4 (American College of Physicians), p. 264.

  8. "Nevertheless, when considering all 15 studies (i.e., those that met both strict and more relaxed criteria) we only noted that regular cannabis users performed worse on memory tests, but that the magnitude of the effect was very small. The small magnitude of effect sizes from observations of chronic users of cannabis suggests that cannabis compounds, if found to have therapeutic value, should have a good margin of safety from a neurocognitive standpoint under the more limited conditions of exposure that would likely obtain in a medical setting."

    Source:  Grant, Igor, et al., "Non-Acute (Residual) Neurocognitive Effects Of Cannabis Use: A Meta-Analytic Study," Journal of the International Neuropsychological Society (Cambridge University Press: July 2003), 9, pp. 687-8.

  9. In spite of the established medical value of marijuana, doctors are presently permitted to prescribe cocaine and morphine - but not marijuana.

    Source: The Controlled Substances Act of 1970, 21 U.S.C. §§ 801 et seq.

  10. Organizations that have endorsed medical access to marijuana include: the Institute of Medicine, the American Academy of Family Physicians; American Bar Association; American Public Health Association; American Society of Addiction Medicine; AIDS Action Council; British Medical Association; California Academy of Family Physicians; California Legislative Council for Older Americans; California Medical Association; California Nurses Association; California Pharmacists Association; California Society of Addiction Medicine; California-Pacific Annual Conference of the United Methodist Church; Colorado Nurses Association; Consumer Reports Magazine; Kaiser Permanente; Lymphoma Foundation of America; Multiple Sclerosis California Action Network; National Association of Attorneys General; National Association of People with AIDS; National Nurses Society on Addictions; New Mexico Nurses Association; New York State Nurses Association; New England Journal of Medicine; and Virginia Nurses Association.

  11. A few of the editorial boards that have endorsed medical access to marijuana include: Boston Globe; Chicago Tribune; Miami Herald; New York Times; Orange County Register; and USA Today.

  12. Many organizations have favorable positions (e.g., unimpeded research) on medical marijuana. These groups include: The Institute of Medicine, The American Cancer Society; American Medical Association; Australian Commonwealth Department of Human Services and Health; California Medical Association; Federation of American Scientists; Florida Medical Association; and the National Academy of Sciences.

  13. The Controlled Substances Act of 1970 established five categories, or "schedules," into which all illicit and prescription drugs were placed. Marijuana was placed in Schedule I, which defines the substance as having a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. To contrast, over 90 published reports and studies have shown marijuana has medical efficacy.

    Source: The Controlled Substances Act of 1970, 21 U.S.C. §§ 801 et seq.; Common Sense for Drug Policy, Compendium of Reports, Research and Articles Demonstrating the Effectiveness of Medical Marijuana, Vol. I & Vol. II (Falls Church, VA: Common Sense for Drug Policy, March 1997).

  14. The U.S. Penal Code states that any person can be imprisoned for up to one year for possession of one marijuana cigarette and imprisoned for up to five years for growing a single marijuana plant.

    Source: The Controlled Substances Act of 1970, 21 U.S.C. §§ 801 et seq.

  15. On September 6, 1988, the Drug Enforcement Administration's Chief Administrative Law Judge, Francis L. Young, ruled:
    "Marijuana, in its natural form, is one of the safest therapeutically active substances known....[T]he provisions of the [Controlled Substances] Act permit and require the transfer of marijuana from Schedule I to Schedule II. It would be unreasonable, arbitrary and capricious for the DEA to continue to stand between those sufferers and the benefits of this substance."

    Source: US Department of Justice, Drug Enforcement Agency, "In the Matter of Marijuana Rescheduling Petition," [Docket #86-22] (September 6, 1988), p. 57.

  16. The DEA's Administrative Law Judge, Francis Young concluded: "In strict medical terms marijuana is far safer than many foods we commonly consume. For example, eating 10 raw potatoes can result in a toxic response. By comparison, it is physically impossible to eat enough marijuana to induce death. Marijuana in its natural form is one of the safest therapeutically active substances known to man. By any measure of rational analysis marijuana can be safely used within the supervised routine of medical care."

    Source: US Department of Justice, Drug Enforcement Agency, "In the Matter of Marijuana Rescheduling Petition," [Docket #86-22], (September 6, 1988), p. 57.

  17. Between 1978 and 1997, 35 states and the District of Columbia passed legislation recognizing marijuana's medicinal value.
    States include: AL, AZ, AR, CA, CO, CT, FL, GA, IL, IA, LA, MA, ME, MI, MN, MO, MT, NV, NH, NJ, NM, NY, NC, OH, OK, OR, RI, SC, TN, TX, VT, VA, WA, WV, and WI.

For additional research on medical marijuana, see this excellent analysis of medical marijuana research by Common Sense for Drug Policy President Kevin B. Zeese and this update from Common Sense for Drug Policy, as well as the Drug War Facts section on marijuana.

copyright © 2003-2010, Coalition for Medical Marijuana
Sponsors Include: American Alliance for Medical Cannabis   --   Americans for Safe Access   --   Angel Justice   --   Angel Wings Patient OutReach, Inc.   --   California NORML   --   CannabisMD   --   Cannabis Action Network   --   Cannabis Consumers Campaign   --   Change The Climate   --   Common Sense for Drug Policy   --   DRCNet   --   Drug Policy Alliance   --   DrugSense   --   Green Aid   --   Human Rights in the Drug War   --   Patients Out of Time   --   Rhode Island Patient Advocacy Coalition   --   Safe Access
info@csdp.org